FDA approved PENBRAYA,the first and only vaccine for prevention of most common serogroups causing meningococcal
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
On Jan. 23, 2020, two independent meningitis B studies were published in the New England Journal of Medicine…
On May 19, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
On Jan. 23, 2015, Novartis announced the US Food and Drug Administration (FDA) had granted accelerated approval of…
On Jun. 20, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
On Aug. 1, 2013, Novartis announced the U.S. Food and Drug Administration (FDA) had approved Menveo (Meningococcal [Groups…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Apr. 22, 2011, The U.S. Food and Drug Administration (FDA) approved the use of Menactra in children…
On Feb. 19, 2010, the U.S. Food and Drug Administration (FDA) announced it had licensed a quadrivalent meningococcal…
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
On Apr. 22, 2005, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had granted licensure to…
In 1930, Sara E. Branham identified a new organism, Neisseria flavescens, as a rare cause of meningitis and…